Contriving

Bioprinting is printing with biological materials

Posted by Dustin on February 20, 2013 No comments

Think of it as 3D printing, but with squishier ingredients! There's a lot of work being done at research labs and big companies like Organovo on print human tissues and human organs, with an eye towards drug testing, and transplantation into humans.
[…]
All this sounds incredible complex, but the fact is that the basic technologies are very accessible – it's all based on inkjet and/or 3D printing! So a bunch of us at BioCurious decided we wanted to play around with this technology ourselves – and the BioPrinter Community Project was born!

DIY BioPrinter
Bioprinting is printing with biological materials. Think of it as 3D printing, but with squishier ingredients! There’s a lot of work being done at res…

Originally posted on Google+ · February 20, 2013

Resveratrol and hearing loss, with a grain of salt

Posted by Dustin on February 20, 2013 1 comment

So, there's a new study that purports to show that resveratrol protects against loss of hearing and cognitive abilities. Good stuff, I say.

I also say that most medical studies turn out to be wrong or to be only kinda right.

Resveratrol shows promise to protect hearing, cognition | ScienceBlog.com
Resveratrol, a substance found in red grapes and red wine, may have the potential to protect against hearing and cognitive decline, according to a published

Originally posted on Google+ · February 20, 2013

Google Glass, I hope it’s as good as it seems

Posted by Dustin on February 20, 2013 3 comments

I hope #googleglass is as good as it seems.

Originally posted on Google+ · February 20, 2013

Patents that will make 3D printers suck for years to come

Posted by Dustin on February 19, 2013 No comments

We've uncovered 10 patents that could severely stifle innovation in the low-cost segment of the 3-D printing market and keep you from making colorful, smooth-finished figures and precise, articulating parts. These patents cover core technologies and ease-of-use features, and could take momentum from the upstarts and return it to the entrenched companies.